Editorial Policy & Evidence Standards
Our standards for synthesizing veterinary clinical research, ensuring factual accuracy, and evaluating canine medical therapies without commercial bias.
1. Hierarchy of Scientific Evidence
All clinical content on o3tek.com is structured around a strict hierarchy of evidence:
- Tier 1: Clinical Consensus Guidelines & Systematic Reviews: Guidelines issued by the International Committee on Allergic Diseases of Animals (ICADA), the American College of Veterinary Dermatology (ACVD), and systematic reviews published in veterinary journals.
- Tier 2: Peer-Reviewed Clinical Trials: Randomized, controlled, blinded trials evaluating the efficacy and safety of pharmaceutical compounds (such as oclacitinib, lokivetmab, and ilunocitinib) and therapeutic diet trials.
- Tier 3: Standard Veterinary Reference Texts: The Merck Veterinary Manual, Plumb's Veterinary Drug Handbook, and clinical resources from accredited veterinary teaching institutions (e.g., Cornell Riney Canine Health Center).
2. Addressing Scientific Controversies & Debunking Ineffective Kits
Where scientific consensus is settled, we state the clinical realities clearly without hedging:
- Commercial At-Home Hair & Saliva Kits: We cite published blinded trials (such as Bernstein et al., 2019) demonstrating that direct-to-consumer saliva and hair allergy tests produce random results indistinguishable from chance. We explicitly advise pet parents against wasting funds on these kits.
- Food Allergy Diagnosis: We firmly maintain that serological blood tests and skin prick tests are scientifically invalid for diagnosing canine food allergies; an unbroken 8–12 week elimination diet trial with hydrolyzed or novel proteins remains the sole diagnostic gold standard.
3. Independence & Commercial Neutrality
We do not accept sponsored content, paid promotional placements, or commissions that compromise our objective evaluation of veterinary treatments. Our comparisons of prescription medications (e.g., Apoquel vs. Zenrelia vs. Cytopoint) objectively report onset speed, monthly cost ranges, documented adverse event profiles, and patient eligibility criteria based on published FDA FOI summaries and manufacturer clinical data.
4. Fact-Checking, Corrections & Updates
Veterinary pharmacological consensus evolves rapidly. Our editorial team systematically reviews existing guides whenever new clinical guidelines are released by ICADA or the ACVD, or when new therapeutic agents receive regulatory approval. If you identify an outdated citation or factual discrepancy, please review our references section on each guide.